Send feedback

MRTFA p.Ser558Leu

c.1673C>T · rs746194227 · VCV1683056

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
AlphaMissense
likely pathogenic
0.5883 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00267%, afr)
Missense predictors
2/2 damaging
AlphaMissense, SaProt · REVEL indeterminate

Computational evidence

Protein change
AlphaMissense0.5883likely pathogenic
REVEL0.374indeterminate
SaProtLLR -11.62damaging
⇒ AlphaMissense and SaProt both call this damaging; REVEL is indeterminate.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 12GERP 2.6, phastCons 1
Regional constrainto/e 1.06unconstrained · MANE · 13 kb · p 0.043 · regional, not allelic
Overall
CADD27.2PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM S458L vs ClinVar S558L) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00267% African / African-American · 2/74,778 alleles
Filtering AF 0.000616% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000474%
Overall 0.00329% 53/1,608,742 alleles · very rare exomes 48/1,456,666 · genomes 5/152,076 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.119% 843
Remaining individualsnot grpmax-eligible 0.00482% 20,760
African / African-Americangrpmax 0.00267% 37,389
European (non-Finnish) 0.0011% 90,629

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MRTFA
Protein
p.Ser558Leu
Coding
c.1673C>T
MANE Select
NM_020831
dbSNP
rs746194227
Type
single nucleotide variant
Location
chr22:40419065 (GRCh38)
Gene constraint
LOEUF 0.389 · pLI 1.00 (gnomAD)
Structure
AlphaFold pLDDT 56.59 · 2 PDB
Residue 458 UniProt numbering
a modified residue (phosphoserine); the 'disordered' region
Full MRTFA gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/mrtfa-p-ser558leu (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown